Mycobacterium marinum infection complicated by anti-tumour necrosis factor therapy

被引：23

作者：

Ramos, Jose M. ^{[1
]}

Garcia-Sepulcre, Mariana F. ^{[2
]}

Rodriguez, Juan C. ^{[3
]}

Padilla, Sergio ^{[1
]}

Gutierrez, Felix ^{[1
]}

机构：

[1] Hosp Gen Univ Elche, Dept Internal Med, Infect Dis Unit, Alicante, Spain

[2] Hosp Gen Univ Elche, Digest Sect, Alicante, Spain

[3] Hosp Gen Univ Elche, Microbiol Sect, Alicante, Spain

来源：

JOURNAL OF MEDICAL MICROBIOLOGY | 2010年 / 59卷 / 05期

关键词：

PATIENT RECEIVING INFLIXIMAB; RHEUMATOID-ARTHRITIS; GRANULOMATOUS INFECTIONS; ETANERCEPT; DISEASE; PNEUMONIA; BLOCKADE;

D O I：

10.1099/jmm.0.017277-0

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Mycobacteria other than tuberculosis infections in patients taking various tumour necrosis factor (TNF)-alpha inhibitors have been reported in the literature We describe sporotrichoid spread of Mycobacterium marinum in a man with Crohn's disease treated with infliximab. After starting ethambutol and rifampicin and discontinuing infliximab, a worsening appeared M. marinum infection may have a potential local spread and systemic dissemination in patients treated with TNF-alpha inhibitors

引用

页码：617 / 621

页数：5

共 24 条

[1]

Boulman N, 2006, CLIN EXP RHEUMATOL, V24, P723

[2] Mycobacterium marinum tenosynovitis in a patient on etanercept therapy for rheumatoid arthritis [J].

Chopra, N ;

Kirschenbaum, AE ;

Widman, D .

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2002, 8 (05) :265-268

[3] Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy [J].

Danko, Janine R. ;

Gilliland, William R. ;

Miller, R. Scott ;

Decker, Catherine F. .

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2009, 41 (04) :252-255

[4] Reintroduction of Etanercept During Treatment of Cutaneous Mycobacterium marinum Infection in a Patient With Ankylosing Spondylitis [J].

Dare, Jason A. ;

Jahan, Shormi ;

Hiatt, Kim ;

Torralba, Karina D. .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (05) :583-586

[5] Mycobacterium chelonae infection associated with adalimumab therapy [J].

Diaz, F. ;

Urkijo, J. C. ;

Mendoza, F. ;

de la Viuda, J. M. ;

Blanco, M. ;

Unzurrunzaga, A. ;

Ayarza, R. .

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 (02) :159-160

[6] Tumor necrosis factor and its blockade in granulomatous infections: Differential modes of action of infliximab and etanercept? [J].

Ehlers, S .

CLINICAL INFECTIOUS DISEASES, 2005, 41 :S199-S203

[7] Mycobacterium marinum infection complicating Crohn's disease, treated with infliximab [J].

Fallon, J. C. ;

Patchett, S. ;

Gulmann, C. ;

Murphy, G. M. .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2008, 33 (01) :43-45

[8] An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases [J].

Griffith, David E. ;

Aksamit, Timothy ;

Brown-Elliott, Barbara A. ;

Catanzaro, Antonino ;

Daley, Charles ;

Gordin, Fred ;

Holland, Steven M. ;

Horsburgh, Robert ;

Huitt, Gwen ;

Iademarco, Michael F. ;

Iseman, Michael ;

Olivier, Kenneth ;

Ruoss, Stephen ;

von Reyn, C. Fordham ;

Wallace, Richard J., Jr. ;

Winthrop, Kevin .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (04) :367-416

[9] Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent [J].

Keane, J ;

Gershon, S ;

Wise, RP ;

Mirabile-Levens, E ;

Kasznica, J ;

Schwieterman, WD ;

Siegel, JN ;

Braun, MM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1098-1104

[10] Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behcet's disease [J].

Malkin, Joanne ;

Shrimpton, Anna ;

Wiselka, Martin ;

Barer, Michael R. ;

Duddridge, Michael ;

Pereral, Nelun .

JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 58 (03) :371-373

← 1 2 3 →